Sitara Peroxide Reports Rs42.88 Million Loss in First Quarter FY2026-27, Improves From Previous Year
Sitara Peroxide Limited has announced its unaudited financial results for the first quarter ended September 30, 2026, reporting a net loss of Rs42.88 million compared with a loss of Rs49.53 million in the corresponding period last year.
According to the financial results submitted to the Pakistan Stock Exchange (PSX), the company recorded an improvement in its quarterly loss, although its financial performance continued to reflect challenging operating conditions.
Loss Per Share Improves to Rs0.78
The company’s loss per share (EPS) stood at Rs0.78 for the quarter ended September 30, 2026, compared with a loss per share of Rs0.90 in the same quarter of the previous year.
The financial statements show that Sitara Peroxide recorded no revenue from contracts with customers during the reporting period. However, other income increased significantly to approximately Rs3.74 million against Rs43,670 in the corresponding quarter last year.
Administrative expenses remained relatively stable at Rs59.38 million, compared with Rs59.34 million in the same period last year. Finance costs declined to Rs586,124 from Rs603,244.
Consequently, the company’s loss before taxation stood at Rs56.22 million, improving from Rs61.40 million in the corresponding period. After accounting for taxation of Rs13.34 million, the company reported a net loss of Rs42.88 million.
Financial Position
As of September 30, 2026, Sitara Peroxide reported total assets of approximately Rs2.45 billion, compared with Rs2.51 billion as of June 30, 2026.
Property, plant and equipment increased to approximately Rs1.92 billion from Rs1.97 billion at the end of the previous financial year. Meanwhile, current assets stood at Rs350.34 million.
The company’s cash and bank balances declined to approximately Rs1.91 million from Rs3.88 million at June 30, 2026, highlighting a reduction in available cash resources.
Operating Cash Flow Remains Under Pressure
The cash flow statement indicated that net cash used in operating activities amounted to Rs20.69 million during the quarter, compared with net cash generated of Rs5.50 million in the corresponding period last year.
The company also reported cash inflows from investing activities, including proceeds related to the disposal of property, plant and equipment. Net cash used in financing activities amounted to Rs7.39 million.
At the end of September 2026, cash and cash equivalents stood at Rs1.91 million.
No Dividend Announced
In its notification dated October 30, 2026, the company’s Board of Directors recommended no interim cash dividend, bonus shares, or right shares for the quarter ended September 30, 2026.
The financial statements were submitted to the Pakistan Stock Exchange, while the company stated that its first-quarter report would be transmitted separately through the Pakistan Unified Corporate Actions and Reporting System (PUCARS).
Outlook
Sitara Peroxide’s first-quarter results show a reduction in its net loss compared with the same period last year. However, the absence of reported revenue, continued administrative expenses, and negative operating cash flow remain important financial challenges.
The company’s future performance will depend on its ability to improve business operations, generate revenue, manage expenses, and strengthen its cash position in the coming quarters.
Investors will likely monitor upcoming financial results for signs of an improvement in operating performance and a return to sustainable profitability.